Portfolio company
INTERATRIAL SHUNT THERAPY
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Alleviant Medical develops a minimally invasive, no-implant interatrial shunt system to treat heart failure by reducing left atrial pressure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.